- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Medivir AB ser. B (MEDIVIR)
2.80
-0.05(-1.75%)
Closed
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.72
2.87
52 wk Range
2.33
6.76
MEDIVIR Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Medivir AB ser. B stock price live, this page displays ST MEDIVIR stock exchange data. View the MEDIVIR premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Medivir AB ser. B real time stock price chart below.
What Is the Medivir AB ser. B Stock Price Today?
The Medivir AB ser. B stock price today is 2.80.
What Is the Stock Symbol for Medivir AB ser. B?
The stock symbol for Medivir AB ser. B is "MEDIVIR."
What Stock Exchange Does Medivir AB ser. B Trade On?
Medivir AB ser. B is listed and trades on the Stockholm stock exchange.
Is Medivir AB ser. B a Good Stock to Buy?
Determining whether Medivir AB ser. B—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MEDIVIR quote. (ISIN: SE0020181014)
What Is the Medivir AB ser. B Stock Price Today?
The Medivir AB ser. B stock price today is 2.80.
What Is the Stock Symbol for Medivir AB ser. B?
The stock symbol for Medivir AB ser. B is "MEDIVIR."
What Stock Exchange Does Medivir AB ser. B Trade On?
Medivir AB ser. B is listed and trades on the Stockholm stock exchange.
Is Medivir AB ser. B a Good Stock to Buy?
Determining whether Medivir AB ser. B—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MEDIVIR quote. (ISIN: SE0020181014)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.722.87
52 wk Range
2.336.76
UnlockMEDIVIR Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Price Target
31.80
Upside
+1,035.84%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Medivir AB ser. B Company Profile
Medivir AB (publ), a pharmaceutical company, focuses on the development and commercialization of treatments for cancer in Nordic region, rest of Europe, and internationally. The company markets Xerclear for the treatment of labial herpes under the Zoviduo name. It is also developing Remetinostat for treating MF cutaneous T-cell lymphoma and basal cell carcinoma, as well as squamous cell carcinoma. In addition, the company is developing MIV-818 for the treatment of liver cancer; MIV-711 to treat osteoarthritis; and Birinapant and IGM-8444 for the treatment of solid tumors, as well as USP-1/TNG348, USP-7, and MBLI/MET-X, which completed preclinical trials for treating cancer and infection. Medivir AB (publ) was incorporated in 1987 and is based in Huddinge, Sweden.
Compare MEDIVIR to Peers and Sector
Metrics to compare | MEDIVIR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMEDIVIRPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.0x | −2.4x | −0.6x | |
PEG Ratio | −0.20 | −0.02 | 0.00 | |
Price/Book | 1.8x | 1.7x | 2.6x | |
Price / LTM Sales | 46.1x | 13.8x | 3.2x | |
Upside (Analyst Target) | 260.8% | 152.3% | 47.1% | |
Fair Value Upside | Unlock | 22.0% | 7.1% | Unlock |
FAQ
What Is the Medivir B (MEDIVIR) Stock Price Today?
The Medivir B stock price today is 2.80
What Stock Exchange Does Medivir B Trade On?
Medivir B is listed and trades on the Stockholm stock exchange.
What Is the Stock Symbol for Medivir B?
The stock symbol for Medivir B is "MEDIVIR."
What Is the Medivir B Market Cap?
As of today, Medivir B market cap is 3.57B.
What is Medivir B Earnings Per Share?
The Medivir B EPS is -1.35.
What Is the Next Medivir B Earnings Date?
Medivir B will release its next earnings report on Nov 06, 2024.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.